Patents by Inventor Maria Luz JARAMILLO

Maria Luz JARAMILLO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AXL-SPECIFIC ANTIBODIES AND USES THEREOF
    Publication number: 20240076389
    Abstract: AXL-specific antibodies and uses therefor are described, including monoclonal and single domain antibodies. Such antibodies bind to cell surface expressed human AXL at an epitope in an immunoglobulin-like (IgL) domain of the AXL ectodomain. The antibody may be used in an antibody-drug conjugate (ADC), for example in the treatment, detection or staging of cancer. The antibody may be biparatopic.
    Type: Application
    Filed: June 27, 2023
    Publication date: March 7, 2024
    Applicant: NATIONAL RESEARCH COUNCIL OF CANADA
    Inventors: Kevin HENRY, Maria Luz JARAMILLO, Colin Roger MACKENZIE, Anne MARCIL
  • AXL-specific antibodies and uses thereof
    Patent number: 11739154
    Abstract: AXL-specific antibodies and uses therefor are described, including monoclonal and single domain antibodies. Such antibodies bind to cell surface expressed human AXL at an epitope in an immunoglobulin-like (IgL) domain of the AXL ectodomain. The antibody may be used in an antibody-drug conjugate (ADC), for example in the treatment, detection or staging of cancer. The antibody may be biparatopic.
    Type: Grant
    Filed: September 10, 2018
    Date of Patent: August 29, 2023
    Assignee: NATIONAL RESEARCH COUNCIL OF CANADA
    Inventors: Kevin Henry, Maria Luz Jaramillo, Colin Roger Mackenzie, Anne Marcil
  • AXL-SPECIFIC ANTIBODIES AND USES THEREOF
    Publication number: 20200277386
    Abstract: AXL-specific antibodies and uses therefor are described, including monoclonal and single domain antibodies. Such antibodies bind to cell surface expressed human AXL at an epitope in an immunoglobulin-like (IgL) domain of the AXL ectodomain. The antibody may be used in an antibody-drug conjugate (ADC), for example in the treatment, detection or staging of cancer. The antibody may be biparatopic.
    Type: Application
    Filed: September 10, 2018
    Publication date: September 3, 2020
    Inventors: Kevin HENRY, Maria Luz JARAMILLO, Colin Roger MACKENZIE, Anne MARCIL